Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Obstipation bei fortgeschrittener Krebserkrankung
Blum D, Praxmarer R. Obstipation bei fortgeschrittener Krebserkrankung. palliative-ch 2009; 3:21-26.
Jan 1, 2009Obstipation bei fortgeschrittener Krebserkrankung
Jan 1, 2009palliative-ch 2009; 3:21-26
Blum David, Praxmarer R
Adenokarzinome des Oesophagus und des Magens: Vergleichende Epidemiologie mit markanten Unterschieden
Inauen R, Ruhstaller T. Adenokarzinome des Oesophagus und des Magens: Vergleichende Epidemiologie mit markanten Unterschieden. Onkologie 2009; 1:6-7.
Jan 1, 2009Adenokarzinome des Oesophagus und des Magens: Vergleichende Epidemiologie mit markanten Unterschieden
Jan 1, 2009Onkologie 2009; 1:6-7
Inauen Roman, Ruhstaller Thomas
Magen- und gastroösophageales Uebergangskarzinom: Diagnostik und Therapieoptionen des frühen bis metastasierten Tumorstadiums
Inauen R, Ruhstaller T. Magen- und gastroösophageales Uebergangskarzinom: Diagnostik und Therapieoptionen des frühen bis metastasierten Tumorstadiums. Onkologie 2009; 1:8-13.
Jan 1, 2009Magen- und gastroösophageales Uebergangskarzinom: Diagnostik und Therapieoptionen des frühen bis metastasierten Tumorstadiums
Jan 1, 2009Onkologie 2009; 1:8-13
Inauen Roman, Ruhstaller Thomas
Gene expression profiling in breast cancer – design of a pooled database to address open questions
Knauer M. Gene expression profiling in breast cancer – design of a pooled database to address open questions. Eur Surg 2009; 41:221-227.
Jan 1, 2009Gene expression profiling in breast cancer – design of a pooled database to address open questions
Jan 1, 2009Eur Surg 2009; 41:221-227
Knauer Michael
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations
Tan D, Kaye S, Norman A, Ardern-Jones A, Shanley S, Eeles R, Bancroft E, Thomas K, Rothermundt C, Gore M. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:5530-6.
Dec 1, 2008"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations
Dec 1, 2008Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:5530-6
Tan David S P, Kaye Stanley B, Norman Andrew, Ardern-Jones Audrey, Shanley Susan, Eeles Rosalind, Bancroft Elizabeth, Thomas Karen, Rothermundt Christian, Gore Martin E
Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer
Früh M, Gillessen Sommer S, Cerny T, Demmer-Steingruber R, D'Addario G. Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2008; 62:344-50.
Dec 1, 2008Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer
Dec 1, 2008Lung cancer (Amsterdam, Netherlands) 2008; 62:344-50
Früh Martin, Gillessen Sommer Silke, Cerny Thomas, Demmer-Steingruber Ruth, D'Addario G
Bevacizumab-associated osteonecrosis of the jaw
Greuter S, Schmid F, Ruhstaller T, Thürlimann B. Bevacizumab-associated osteonecrosis of the jaw. Ann Oncol 2008; 19:2091-2.
Dec 1, 2008Bevacizumab-associated osteonecrosis of the jaw
Dec 1, 2008Ann Oncol 2008; 19:2091-2
Greuter S, Schmid F, Ruhstaller Thomas, Thürlimann Beat
A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function
Siano M, Gallino A, Sessa C, Mora O, Leoncini L, Oberson M, Rodriguez-Abreu D, Zucca E, Negretti L, Lerch E, Ghielmini M. A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function. Clinical cancer research : an official journal of the American Association for Cancer Research 2008; 14:7935-9.
Dec 1, 2008A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function
Dec 1, 2008Clinical cancer research : an official journal of the American Association for Cancer Research 2008; 14:7935-9
Siano Marco, Gallino Augusto, Sessa Cristiana, Mora Oreste, Leoncini Leda, Oberson Michel, Rodriguez-Abreu Delvys, Zucca Emanuele, Negretti Laura, Lerch Erika, Ghielmini Michele
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C, Ladewig A, Hsu-Schmitz S, Gueller U, Zuber M. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2008; 35:805-13.
Nov 28, 2008Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
Nov 28, 2008Eur J Surg Oncol 2008; 35:805-13
Langer I, Oertli D, Harder F, Wight E, Moch H, Viehl C T, Ladewig A, Hsu-Schmitz S F, Gueller Ulrich, Zuber M
Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
Knauer M, Wenzl E, Offner F, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A. Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer. Eur J Surg Oncol 2008; 35:798-804.
Nov 14, 2008Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
Nov 14, 2008Eur J Surg Oncol 2008; 35:798-804
Knauer Michael, Wenzl E, Offner F A, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Viale G, Olszewski W, Knox F, Thürlimann B, Price K, Castiglione-Gertsch M, Gelber R, Gusterson B, Goldhirsch A, Orosz Z, Neven P, Öhlschlegel C, Giobbie-Hurder A, Regan M, Coates A, Mastropasqua M, Dell'Orto P, Maiorano E, MacGrogan G, Braye S, Breast International Group Trial 1-98. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 2008; 26:5569-75.
Nov 3, 2008Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Nov 3, 2008J Clin Oncol 2008; 26:5569-75
Viale Giuseppe, Olszewski Wojciech P, Knox Fiona, Thürlimann Beat, Price Karen N, Castiglione-Gertsch Monica, Gelber Richard D, Gusterson Barry A, Goldhirsch Aron, Orosz Zsolt, Neven Patrick, Öhlschlegel Christian, Giobbie-Hurder Anita, Regan Meredith M, Coates Alan S, Mastropasqua Mauro G, Dell'Orto Patrizia, Maiorano Eugenio, MacGrogan Gaëtan, Braye Stephen G, Breast International Group Trial 1-98
Wie (und was) spricht man mit Sterbenden?
Renz M. Wie (und was) spricht man mit Sterbenden?. Stadtgottes 2008:28-30.
Nov 1, 2008Wie (und was) spricht man mit Sterbenden?
Nov 1, 2008Stadtgottes 2008:28-30
Renz Monika
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Grimm B, Padberg B, Ruhstaller T, Fleisch F, von Moos R. Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie 2008; 31:620-2.
Nov 1, 2008Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Nov 1, 2008Onkologie 2008; 31:620-2
Grimm Birgit, Padberg Barbara, Ruhstaller Thomas, Fleisch Felix, von Moos Roger
Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels
Kessler T, Reich M, Jahn G, Tolosa E, Beck A, Kalbacher H, Overkleeft H, Schempp S, Driessen C. Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels. The Journal of general virology 2008; 89:2427-36.
Oct 1, 2008Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels
Oct 1, 2008The Journal of general virology 2008; 89:2427-36
Kessler Tobias, Reich Michael, Jahn Gerhard, Tolosa Eva, Beck Alexander, Kalbacher Hubert, Overkleeft Herman, Schempp Susanne, Driessen Christoph
CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Jörger M, Nuessli D, Henz S, Zaunbauer W, Cerny T, Cogliatti S, Gillessen Sommer S. CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study. Onkologie 2008; 31:514-9.
Oct 1, 2008CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Oct 1, 2008Onkologie 2008; 31:514-9
Jörger Markus, Nuessli Dominique, Henz Samuel, Zaunbauer Wolfgang, Cerny Thomas, Cogliatti Sergio B., Gillessen Sommer Silke
Metastatic bone pain: treatment options with an emphasis on bisphosphonates
von Moos R, Strasser F, Gillessen Sommer S, Zaugg K. Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15.
Oct 1, 2008Metastatic bone pain: treatment options with an emphasis on bisphosphonates
Oct 1, 2008Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15
von Moos Roger, Strasser Florian, Gillessen Sommer Silke, Zaugg Kathrin
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
Fissolo N, Kraus M, Reich M, Ayturan M, Overkleeft H, Driessen C, Weissert R. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. European journal of immunology 2008; 38:2401-11.
Sep 1, 2008Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
Sep 1, 2008European journal of immunology 2008; 38:2401-11
Fissolo Nicolas, Kraus Marianne, Reich Michael, Ayturan Miriam, Overkleeft Herman, Driessen Christoph, Weissert Robert
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Ribi K, Stahel R, Ris H, Stupp R, Schmid R, Betticher D, Jörger M, Bodis S, Weder W, Schuller J, Bernhard J, Swiss Group for Clinical Cancer Research SAKK. Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung cancer (Amsterdam, Netherlands) 2008; 61:398-404.
Sep 1, 2008Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Sep 1, 2008Lung cancer (Amsterdam, Netherlands) 2008; 61:398-404
Ribi Karin, Stahel Rolf A, Ris Hans-Beat, Stupp Roger, Schmid Ralph A, Betticher Daniel, Jörger Markus, Bodis Stephan, Weder Walter, Schuller Jan C, Bernhard Jürg, Swiss Group for Clinical Cancer Research SAKK
Surgeon-dependent predictive factors for mortality after elective colorectal resection and immediate anastomosis for cancer or nonacute diverticular disease: multivariable analysis of 2,605 patients
Muscari F, Fingerhut A, Dziri C, Lorimier G, Gueller U, Fourtanier G, Flamant Y, Hay J, Msika S, Suc B, French Federation for Surgical Research. Surgeon-dependent predictive factors for mortality after elective colorectal resection and immediate anastomosis for cancer or nonacute diverticular disease: multivariable analysis of 2,605 patients. J Am Coll Surg 2008; 207:888-95.
Aug 30, 2008Surgeon-dependent predictive factors for mortality after elective colorectal resection and immediate anastomosis for cancer or nonacute diverticular disease: multivariable analysis of 2,605 patients
Aug 30, 2008J Am Coll Surg 2008; 207:888-95
Muscari Fabrice, Fingerhut Abe, Dziri Chadli, Lorimier Gérard, Gueller Ulrich, Fourtanier Gilles, Flamant Yves, Hay Jean-Marie, Msika Simon, Suc Bertrand, French Federation for Surgical Research
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Gruber G, Gusterson B, Viale G, Goldhirsch A, Price K, Coates A, Gelber R, Fey M, Simoncini E, Thürlimann B, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S, Castiglione-Gertsch M, Cole B, International Breast Cancer Study Group. Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol 2008; 19:1393-401.
Aug 1, 2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Aug 1, 2008Ann Oncol 2008; 19:1393-401
Gruber G, Gusterson B A, Viale G, Goldhirsch A, Price K N, Coates A S, Gelber R D, Fey M F, Simoncini E, Thürlimann Beat, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S B, Castiglione-Gertsch M, Cole B F, International Breast Cancer Study Group